Parabilis Medicines, Inc. (PBLS)
R&D Expenses
$152.85M
TTM · Period ending: · USD

PBLS R&D Expenses
What is r&d expenses?
Research and development spending.
PBLS r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 125,583,000 | |
| 100,829,000 |
Frequently asked questions: PBLS r&d expenses
What is Parabilis Medicines, Inc. (PBLS)'s current r&d expenses?
Parabilis Medicines, Inc. (PBLS)'s latest reported r&d expenses (TTM) is $152.85M as of Sep 30, 2026. Research and development spending.
How much historical r&d expenses data is available for PBLS?
Stock Alarm Pro provides 2 dated annual fiscal periods observations for Parabilis Medicines, Inc. (PBLS)'s r&d expenses, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare PBLS's r&d expenses to peers or set an alert?
You can open PBLS's r&d expenses in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on PBLS delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance